These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4204508)

  • 21. [Sensitivity of clinical strains of Ps. aeruginosa to aminoglycoside antibiotics, carbenicillin and their combinations].
    Fomina IP; Kuznetsova SM; Navashin SM
    Antibiotiki; 1970 Dec; 15(12):1094-8. PubMed ID: 4322741
    [No Abstract]   [Full Text] [Related]  

  • 22. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tobramycin. In vitro action of a new aminoside. Comparative study in 2 hospital centers].
    Morel C; Freymuth F; Nevot P; Kazmierczak A; Philippon A; Paul G
    Nouv Presse Med; 1973 May; 2(18):1219-23. PubMed ID: 4197620
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D; Majtán V
    Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tobramycin treatment of pseudomonas aeruginosa infections in cystic fibrosis.
    Hoff GE; Schiotz PO; Paulsen J
    Scand J Infect Dis; 1974; 6(4):333-7. PubMed ID: 4217466
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibiotic synergy: clinical applications and an in vitro study of cefotaxime-aminoglycoside combinations.
    Faris HM; Dreskin RB
    J S C Med Assoc; 1983 May; 79(5):275-7. PubMed ID: 6308348
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetic studies of tobramycin and gentamicin.
    Simon VK; Mösinger EU; Malerczy V
    Antimicrob Agents Chemother; 1973 Apr; 3(4):445-50. PubMed ID: 4208289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic associations on acting Pseudomonas aeruginosa].
    Duval J; Mathieu-Saint-Laurent P; Soussy CL
    Pathol Biol (Paris); 1971; 19(11):637-48. PubMed ID: 4997792
    [No Abstract]   [Full Text] [Related]  

  • 30. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa.
    Alipour M; Suntres ZE; Omri A
    J Antimicrob Chemother; 2009 Aug; 64(2):317-25. PubMed ID: 19465435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
    Thabaut A; Durosoir JL; Meyran M
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H107, a new aminoglycoside anti-Pseudomonas antibiotic produced by a new strain of Spirillospora.
    Hacène H; Daoudi-Hamdad F; Bhatnagar T; Baratti JC; Lefebvre G
    Microbios; 2000; 102(402):69-77. PubMed ID: 10885497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage.
    Knothe H; Lebek G; Krcméry V; Seginková Z; Cervenka J; Antal M; Mitsuhashi S
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):506-10. PubMed ID: 6800151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.
    Rukholm G; Mugabe C; Azghani AO; Omri A
    Int J Antimicrob Agents; 2006 Mar; 27(3):247-52. PubMed ID: 16472992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
    Schurek KN; Marr AK; Taylor PK; Wiegand I; Semenec L; Khaira BK; Hancock RE
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4213-9. PubMed ID: 18824604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
    Cai Y; Fan Y; Wang R; An MM; Liang BB
    J Antimicrob Chemother; 2009 Sep; 64(3):563-6. PubMed ID: 19561148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aminoglycoside antibiotics].
    Tanaka N
    Nihon Rinsho; 1981 Jan; 39(1):49-57. PubMed ID: 6793750
    [No Abstract]   [Full Text] [Related]  

  • 39. Tobramycin: bacteriological evaluation.
    Burger LM; Sanford JP; Zweighaft T
    Am J Med Sci; 1973 Feb; 265(2):135-42. PubMed ID: 4196741
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.
    Reller LB; Schoenknecht FD; Kenny MA; Sherris JC
    J Infect Dis; 1974 Nov; 130(5):454-63. PubMed ID: 4370727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.